Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 2.13 | 2.2 |
NAV | ₹17.40 | ₹96.85 |
Fund Started | 13 Aug 2021 | 25 Mar 1997 |
Fund Size | ₹1248.91 Cr | ₹1084.99 Cr |
Exit Load | Exit load of 1% if redeemed within 365 days. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 13.21% | 16.24% |
3 Year | 17.91% | 22.01% |
5 Year | - | 23.14% |
1 Year
3 Year
5 Year
Equity | 95.58% | 99.31% |
Cash | 4.42% | 0.69% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 6.88% |
HDFC Bank Ltd. | 6.85% |
Infosys Ltd. | 4.91% |
Bharti Airtel Ltd. | 3.85% |
Reliance Industries Ltd. | 3.66% |
NTPC Ltd. | 3.59% |
Varun Beverages Ltd. | 2.89% |
Larsen & Toubro Ltd. | 2.69% |
Brigade Enterprises Ltd. | 2.62% |
State Bank of India | 2.52% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.21% |
Infosys Ltd. | 4.57% |
ICICI Bank Ltd. | 4.12% |
Dr. Reddy's Laboratories Ltd. | 3.14% |
State Bank of India | 2.74% |
NTPC Ltd. | 2.64% |
REC Ltd. | 2.49% |
Tech Mahindra Ltd. | 2.23% |
Amber Enterprises India Ltd. | 2.16% |
Suven Pharmaceuticals Ltd. | 2.07% |
Name | Silky Jain | Satish Ramanathan |
Start Date | 01 Oct 2021 | 01 Oct 2024 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instrument, with higher focus on value stocks. | The scheme aims to provide long term capital growth by investing primarily in a well-diversified portfolio of undervalued securities. |
Launch Date | 13 Aug 2021 | 25 Mar 1997 |
Description
Launch Date